Literature DB >> 16335537

Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.

Claudia Götz1, Sabine Kartarius, Sarah Schetting, Mathias Montenarh.   

Abstract

Both, the activity as well as the expression of protein kinase CK2 is enhanced in various cancer types and in established tumour cell lines. This phenomenon is not due to an increase in the CK2 message but rather to posttranscriptional and posttranslational mechanisms. In order to get an insight into these posttranslational modifications we analyzed CK2 in prostate cancer cell lines, which differ by their hormone-sensitivity. We found that the CK2 activity is significantly higher in hormone-refractory than in hormone-sensitive cells although the amount of the catalytic alpha- and alpha'- subunits is comparable. In contrast, we detected seemingly lower amounts of the regulatory beta-subunit in the hormone-refractory cell lines, which later turned out to be an immunologically defined subclass. This subclass is realized by a phosphate group, which is attached to serine 209. The phosphorylation occurs in vivo during mitosis and is executed by the p34(cdc2)/cyclin B kinase. As this phosphorylation enhances the CK2 activity this change might well account for the higher activity of CK2 in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16335537     DOI: 10.1007/s11010-005-2950-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Unmasking of phosphorylation-sensitive epitopes on p53 and Mdm2 by a simple Western-phosphatase procedure.

Authors:  R Maya; M Oren
Journal:  Oncogene       Date:  2000-06-29       Impact factor: 9.867

2.  Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells.

Authors:  Andrea Hessenauer; Mathias Montenarh; Claudia Götz
Journal:  Int J Oncol       Date:  2003-06       Impact factor: 5.650

3.  Autocatalytic tyrosine-phosphorylation of protein kinase CK2 alpha and alpha' subunits: implication of Tyr182.

Authors:  A Donella-Deana; L Cesaro; S Sarno; A M Brunati; M Ruzzene; L A Pinna
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase.

Authors:  M Sayed; S O Kim; B S Salh; O G Issinger; S L Pelech
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Phosphorylation regulates the stability of the regulatory CK2beta subunit.

Authors:  Cunjie Zhang; Greg Vilk; David A Canton; David W Litchfield
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

7.  Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria.

Authors:  N Grankowski; B Boldyreff; O G Issinger
Journal:  Eur J Biochem       Date:  1991-05-23

8.  Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.

Authors:  I R Rifkin; P L Channavajhala; H L Kiefer; A J Carmack; E Landesman-Bollag; B C Beaudette; B Jersky; D J Salant; S T Ju; A Marshak-Rothstein; D C Seldin
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

9.  Isolation and characterization of a monoclonal anti-protein kinase CK2 beta-subunit antibody of the IgG class for the direct detection of CK2 beta-subunit in tissue cultures of various mammalian species and human tumors.

Authors:  W Nastainczyk; I Schmidt-Spaniol; B Boldyreff; O G Issinger
Journal:  Hybridoma       Date:  1995-08

10.  Ser2 is the autophosphorylation site in the beta subunit from bicistronically expressed human casein kinase-2 and from native rat liver casein kinase-2 beta.

Authors:  B Boldyreff; P James; W Staudenmann; O G Issinger
Journal:  Eur J Biochem       Date:  1993-12-01
View more
  2 in total

Review 1.  [Role of androgen receptors in hormone-refractory prostate cancer: molecular basics and experimental therapy approaches].

Authors:  L Rinnab; A Hessenauer; S V Schütz; E Schmid; R Küfer; F Finter; R E Hautmann; K D Spindler; M V Cronauer
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

Review 2.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.